Menü
Das neue sharewise ist da Übersichtlicher, schneller, mit heller und dunkler Ansicht — und allem, was du kennst. Jetzt ausprobieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

The Beauty Health Company (SKIN) Reports Q3 Loss, Tops Revenue Estimates
The Beauty Health Company (SKIN) Reports Q3 Loss, Tops Revenue Estimates

The Beauty Health Company (SKIN) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.15 per share a year ago

Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates
Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates

Lifecore Biomedical (LFCR) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.3. This compares to a loss of $0.53 per share a year ago. These

PAR Technology (PAR) Misses Q3 Earnings Estimates
PAR Technology (PAR) Misses Q3 Earnings Estimates

PAR Technology (PAR) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to a loss of $0.09 per share a year ago. These

Onto Innovation (ONTO) Tops Q3 Earnings Estimates
Onto Innovation (ONTO) Tops Q3 Earnings Estimates

Onto Innovation (ONTO) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $1.34 per share a year ago. These

MP Materials Corp. (MP) Reports Q3 Loss, Tops Revenue Estimates
MP Materials Corp. (MP) Reports Q3 Loss, Tops Revenue Estimates

MP Materials Corp. (MP) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.12 per share a year ago. These figures

Figs (FIGS) Beats Q3 Earnings and Revenue Estimates
Figs (FIGS) Beats Q3 Earnings and Revenue Estimates

Figs (FIGS) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to a loss of $0.01 per share a year ago. These figures are

Huntsman (HUN) Reports Q3 Loss, Tops Revenue Estimates
Huntsman (HUN) Reports Q3 Loss, Tops Revenue Estimates

Huntsman (HUN) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to earnings of $0.1 per share a year ago. These figures are

Zymeworks Inc. (ZYME) Reports Q3 Loss, Lags Revenue Estimates
Zymeworks Inc. (ZYME) Reports Q3 Loss, Lags Revenue Estimates

Zymeworks Inc. (ZYME) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.3. This compares to a loss of $0.39 per share a year ago. These figures

Universal Logistics (ULH) Beats Q3 Earnings EstimatesPhoto, wide shot, wide-angle lens,  Janitorial service, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/4d4e885c-79e9-4b8f-bd91-e9721cd7c2e9.png
Universal Logistics (ULH) Beats Q3 Earnings Estimates

Universal Logistics (ULH) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $1.01 per share a year ago. These

Five9 (FIVN) Tops Q3 Earnings and Revenue Estimates
Five9 (FIVN) Tops Q3 Earnings and Revenue Estimates

Five9 (FIVN) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $0.67 per share a year ago. These figures are

Microchip Technology (MCHP) Q2 Earnings and Revenues Top Estimates
Microchip Technology (MCHP) Q2 Earnings and Revenues Top Estimates

Microchip Technology (MCHP) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.46 per share a year ago

Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates

Eton Pharmaceuticals, Inc. (ETON) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of $0.13. This compares to earnings of $0.02 per share a year ago. These

BioLife Solutions, Inc. (BLFS) Surpasses Q3 Earnings and Revenue Estimates
BioLife Solutions, Inc. (BLFS) Surpasses Q3 Earnings and Revenue Estimates

BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to a loss of $0.02 per share a

VTEX (VTEX) Meets Q3 Earnings Estimates
VTEX (VTEX) Meets Q3 Earnings Estimates

VTEX (VTEX) came out with quarterly earnings of $0.03 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.02 per share a year ago. These figures are adjusted for

EOG Resources (EOG) Surpasses Q3 Earnings Estimates
EOG Resources (EOG) Surpasses Q3 Earnings Estimates

EOG Resources (EOG) came out with quarterly earnings of $2.71 per share, beating the Zacks Consensus Estimate of $2.43 per share. This compares to earnings of $2.89 per share a year ago. These

Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates
Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates

Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.31 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.36 per share a year ago. These figures

Camden (CPT) Tops Q3 FFO Estimates
Camden (CPT) Tops Q3 FFO Estimates

Camden (CPT) came out with quarterly funds from operations (FFO) of $1.7 per share, beating the Zacks Consensus Estimate of $1.69 per share. This compares to FFO of $1.71 per share a year ago. These

Dropbox (DBX) Q3 Earnings and Revenues Beat Estimates
Dropbox (DBX) Q3 Earnings and Revenues Beat Estimates

Dropbox (DBX) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $0.6 per share a year ago. These figures are

Solventum (SOLV) Surpasses Q3 Earnings and Revenue Estimates
Solventum (SOLV) Surpasses Q3 Earnings and Revenue Estimates

Solventum (SOLV) came out with quarterly earnings of $1.5 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.64 per share a year ago. These figures

Block (XYZ) Misses Q3 Earnings and Revenue Estimates
Block (XYZ) Misses Q3 Earnings and Revenue Estimates

Block (XYZ) came out with quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.88 per share a year ago. These figures are

Celanese (CE) Beats Q3 Earnings Estimates
Celanese (CE) Beats Q3 Earnings Estimates

Celanese (CE) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $2.44 per share a year ago. These figures are

Monster Beverage (MNST) Surpasses Q3 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Restaurant, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/57273392-070f-46de-9297-125616327242.png
Monster Beverage (MNST) Surpasses Q3 Earnings and Revenue Estimates

Monster Beverage (MNST) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.4 per share a year ago. These

Doximity (DOCS) Tops Q2 Earnings and Revenue Estimates
Doximity (DOCS) Tops Q2 Earnings and Revenue Estimates

Doximity (DOCS) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.3 per share a year ago. These figures

Akamai Technologies (AKAM) Beats Q3 Earnings and Revenue Estimates
Akamai Technologies (AKAM) Beats Q3 Earnings and Revenue Estimates

Akamai Technologies (AKAM) came out with quarterly earnings of $1.86 per share, beating the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $1.59 per share a year ago

Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Misses Revenue Estimates
Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Misses Revenue Estimates

Intellia Therapeutics, Inc. (NTLA) came out with a quarterly loss of $0.92 per share versus the Zacks Consensus Estimate of a loss of $1.02. This compares to a loss of $1.34 per share a year ago